Citadel Advisors’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Citadel Advisors’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$431	–	15543
2023 Q3	$431	Sell	500 -29,700	-98%	-$32.5K	﹤0.01%	14057
2023 Q2	$36.2K	Buy	30,200 +28,300	+1,489%	+$142K	﹤0.01%	12152
2023 Q1	$16.6K	Buy	1,900 +1,800	+1,800%	+$16.6K	﹤0.01%	13193
2022 Q4	$800	Buy	+100	New	+$628	﹤0.01%	14581

Citadel Advisors's RAIN Position: Q1 2024 in Review

Citadel Advisors sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 28,491 shares — an estimated $34.2K sold.

Citadel Advisors first reported a position in RAIN in Q2 2022 and held it in 6 quarters. The position peaked at $328K in Q3 2022. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Citadel Advisors reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Citadel Advisors sold 28,491 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $34.2K.
Citadel Advisors first reported a position in Rain Oncology Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Citadel Advisors's Rain Oncology Inc. Common Stock position peaked at $328K in Q3 2022.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.